According to our (Global Info Research) latest study, the global Synthetic Vascular Grafts market size was valued at US$ 502 million in 2025 and is forecast to a readjusted size of US$ 646 million by 2032 with a CAGR of 3.6% during review period.
In 2025, the global sales volume of synthetic vascular grafts was approximately 415 K Units, with an average selling price of about US$1,175 per Unit. Synthetic vascular grafts are implantable tubular vascular substitutes made primarily from synthetic polymers such as expanded polytetrafluoroethylene, polyester, or polyurethane. They are commonly manufactured using expanded porous, woven, knitted, or multilayer composite structures and may incorporate collagen sealing, heparin treatment, or external reinforcement to improve leakage resistance, blood compatibility, kink resistance, and surgical handling. These products restore blood flow when autologous vessels are unsuitable for reconstruction and are mainly used in aortic replacement, peripheral arterial bypass, hemodialysis vascular access, and other open vascular reconstruction procedures.
Market growth is primarily supported by population aging and the rising prevalence of aortic aneurysms, peripheral arterial disease, and end-stage kidney disease. Synthetic vascular grafts remain important surgical options for patients without suitable autologous vessels, those requiring large-vessel replacement, and patients needing durable hemodialysis access. Product advances such as early-cannulation designs, heparin treatment, pre-sealing, and antimicrobial technologies are improving patency, hemostasis, and surgical handling, supporting the adoption of higher-value grafts. Expanding vascular surgery capabilities, dialysis infrastructure, and local product approvals in China, India, Southeast Asia, and Latin America are also increasing product accessibility and supporting demand.
This report is a detailed and comprehensive analysis for global Synthetic Vascular Grafts market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Synthetic Vascular Grafts market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Synthetic Vascular Grafts market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Synthetic Vascular Grafts market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Synthetic Vascular Grafts market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Synthetic Vascular Grafts
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Synthetic Vascular Grafts market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include W. L. Gore & Associates, Inc., Getinge AB, Terumo Corporation, Becton, Dickinson and Company, B. Braun SE, LeMaitre Vascular, Inc., Artivion, Inc., Vygon SA, Japan Lifeline Co., Ltd., Nipro Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Synthetic Vascular Grafts market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Unbranched Vascular Grafts
Bifurcated Vascular Grafts
Multibranched Vascular Grafts
Other Special Geometry Vascular Grafts
Market segment by Material
ePTFE Vascular Grafts
Polyester Vascular Grafts
Polyurethane Vascular Grafts
Other Synthetic Material Vascular Grafts
Market segment by Pre-Sealing Status
Three-Dimensional Imaging Compatible
Two-Dimensional Fluoroscopy Compatible
Other
Market segment by Application
Aortic Reconstruction
Peripheral Arterial Reconstruction
Hemodialysis Vascular Access
Other
Major players covered
W. L. Gore & Associates, Inc.
Getinge AB
Terumo Corporation
Becton, Dickinson and Company
B. Braun SE
LeMaitre Vascular, Inc.
Artivion, Inc.
Vygon SA
Japan Lifeline Co., Ltd.
Nipro Corporation
VUP Medical, a.s.
Tricomed S.A.
BIOVIC Sdn. Bhd.
PECA Labs, Inc.
Vascular Flow Technologies Limited
Jiangsu Bioda Life Science Co., Ltd.
Shanghai Chester Medical Technology Co., Ltd.
Indústrias H. A. Barone Ltda.
Scientific Production Complex Ecoflon Joint Stock Company
Medtechnoproekt
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Synthetic Vascular Grafts product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Synthetic Vascular Grafts, with price, sales quantity, revenue, and global market share of Synthetic Vascular Grafts from 2021 to 2026.
Chapter 3, the Synthetic Vascular Grafts competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Synthetic Vascular Grafts breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Synthetic Vascular Grafts market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Synthetic Vascular Grafts.
Chapter 14 and 15, to describe Synthetic Vascular Grafts sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Synthetic Vascular Grafts. Industry analysis & Market Report on Synthetic Vascular Grafts is a syndicated market report, published as Global Synthetic Vascular Grafts Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Synthetic Vascular Grafts market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.